Evidence map›Paper›PMID 39075672›Full record

SynthesisJournal of cutaneous medicine and surgery

Treatment of Post-Inflammatory Hyperpigmentation in Skin of Colour: A Systematic Review.

Kristie Mar, Bushra Khalid, Mahan Maazi, Rayan Ahmed, Ou Jia Emilie Wang, Touraj Khosravi-Hafshejani

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of cutaneous medicine and surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Cutaneous Aging in Skin of Color: A Narrative Review.American journal of clinical dermatology · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Moranoline-EnrichedInternational journal of molecular sciences · 2026
    Article
  12. Review
  13. Article
  14. Review
  15. Global consensus on the management of melanin hyperpigmentation disorders.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kristie MarFaculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-2482-8633
Bushra KhalidFaculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Mahan MaaziFaculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0009-0003-3014-6182
Rayan AhmedFaculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Ou Jia Emilie WangFaculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Touraj Khosravi-HafshejaniDepartment of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post inflammatory hyperpigmentation (PIH) affects all skin types with a heightened predilection for darker skin tones. Its course is chronic once developed and treatment is often difficult. This systematic review aims to summarize the treatment outcomes for PIH with a focus on skin of colour (SOC) individuals. A literature search was conducted using MEDLINE (from 1946), Embase (from 1974), PubMed, and Cochrane in adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guideline. Results from 48 studies summarized 1356 SOC individuals. The mean age was 29 years (n = 1036) and 78% were female (n = 786). The ethnic prevalence was 70% Black, 27% Asian, and 3% Latin. Overall, 20% were Fitzpatrick skin type (FST) III, 40% FST IV, 34% FST V, and 6% FST VI. Most cases were precipitated by inflammatory conditions (89%) and localized to the face (83%). The most frequently reported interventions were topical retinoids (22%) and laser therapy (17%). Partial improvement was seen in 85% and 66% of participants, respectively. Laser was the only intervention that offered complete resolution in a subgroup of patients (26%); however, there were reported cases of PIH exacerbation following treatment. Chemical peels (9%) and hydroquinone (7%) were among other treatments with less effective outcomes. PIH and its persistence is a prevalent issue, significantly affecting many affected individuals with darker skin tones. Our results show a lack of robust efficacy across all treatment modalities. There is considerable room for improvement in interventions for at-risk populations.

Indexed as

HyperpigmentationSkin PigmentationEthnicityFemaleHumansLaser TherapyRetinoidsRetinoidsFSThydroquinonelaserPIHretinoidSOC

Identifiers

PMID39075672
PMCPMC11514325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.